Skip to content

April 27, 2026

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
M&A / Deals
Sun Pharma to acquire Organon for $11.75bn

M&A / Deals

Sun Pharma to acquire Organon for $11.75bn

Pharmaceutical Technology

Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.

Read full story

pharminent April 27, 2026 (Last updated: April 27, 2026)

Pharmaceutical Technology

Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.

Read full story

Post navigation

Previous: Sun sets out $11.75bn takeover play for Organon

Next: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention

Related Stories

M&A / Deals

Eli Lilly acquires Ajax Therapeutics for first-in-class JAK2 inhibitor in myelofibrosis

pharminent April 27, 2026

M&A / Deals

Sun sets out $11.75bn takeover play for Organon

pharminent April 27, 2026

M&A / Deals

Avalyn seeks public debut to support new lung drug formulations

pharminent April 24, 2026

You May Have Missed

Other

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

pharminent April 27, 2026

Pipeline

Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases

pharminent April 27, 2026

Policy / Pricing

J&J puts blockbuster blood thinner Xarelto on TrumpRx

pharminent April 27, 2026

M&A / Deals

Eli Lilly acquires Ajax Therapeutics for first-in-class JAK2 inhibitor in myelofibrosis

pharminent April 27, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.